| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 129, 277-286, Copyright © 1991 by Endocrine Society
ARTICLES |
N Batticane, MC Morale, F Gallo, Z Farinella and B Marchetti
Department of Pharmacology, University of Catania Medical School, Italy.
The marked modulation of lymphocyte function exerted by the hypothalamic decapetide LHRH prompted us to study the possible involvement of the neuropeptide in one of the major steps of lymphocyte proliferation, namely the expression of interleukin-2 (IL-2) receptor during in vitro treatment of rat lymphocytes with LHRH agonists (LHRH- A) or antagonists (LHRH-ANTA). The basal proliferative activity of splenocytes and thymocytes from proestrous female rats was significantly stimulated after incubation with LHRH and LHRH-A, but not LHRH fragments [LHRH-(1-3), LHRH-(1-5), and LHRH-(2-6)]. Similarly, in the absence of the mitogenic stimulus, IL-2 receptor expression was significantly stimulated in thymocyte and splenocyte cultures incubated with increasing doses of LHRH or its agonists. The amplification of Concanavalin-A-induced increase in blastogenic transformation of lymphocytes by LHRH was paralleled by a significant stimulation of IL-2 receptor expression. The specificity of such effect was demonstrated by 1) the failure of LHRH fragments [LHRH-(1-6)] to mimick the LHRH stimulatory effect; and 2) the complete reversal produced by simultaneous addition of a potent LHRH-ANTA on IL-2 receptor expression induced by LHRH. Moreover, basal and lectin stimulation of IL-2 receptor-positive cells were significantly inhibited by treatment with the LHRH-ANTA. These data clearly demonstrate that 1) LHRH induction of lymphocyte activation in vitro is accompanied by a specific increase in IL-2 receptor-positive cells; 2) endogenous lymphocyte LHRH may participate in stimulation of IL-2 receptor expression under both basal and stimulated conditions, suggesting that LHRH signaling at the lymphocyte may interact synergistically with intracellular mechanisms responsible for lymphocyte activation.
This article has been cited by other articles:
![]() |
D. -A. Laplaud, E. Leray, P. Barriere, S. Wiertlewski, and T. Moreau Increase in multiple sclerosis relapse rate following in vitro fertilization Neurology, April 25, 2006; 66(8): 1280 - 1281. [Full Text] [PDF] |
||||
![]() |
M. Enomoto, M. Utsumi, and M. K. Park Gonadotropin-Releasing Hormone Induces Actin Cytoskeleton Remodeling and Affects Cell Migration in a Cell-Type-Specific Manner in TSU-Pr1 and DU145 Cells Endocrinology, January 1, 2006; 147(1): 530 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Sutherland, G. L. Goldberg, M. V. Hammett, A. P. Uldrich, S. P. Berzins, T. S. Heng, B. R. Blazar, J. L. Millar, M. A. Malin, A. P. Chidgey, et al. Activation of Thymic Regeneration in Mice and Humans following Androgen Blockade J. Immunol., August 15, 2005; 175(4): 2741 - 2753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Jacobson and M. A. Ansari Immunomodulatory Actions of Gonadal Steroids May Be Mediated by Gonadotropin-Releasing Hormone Endocrinology, January 1, 2004; 145(1): 330 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ansari, M. Dhar, S. Spieker, N. Bakht, A. M. Rahman, W. V. Moore, and J. D. Jacobson Modulation of Diabetes with Gonadotropin-Releasing Hormone Antagonists in the Nonobese Mouse Model of Autoimmune Diabetes Endocrinology, January 1, 2004; 145(1): 337 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Dixit, H. Yang, V. Udhayakumar, and R. Sridaran Gonadotropin-Releasing Hormone Alters the T Helper Cytokine Balance in the Pregnant Rat Biol Reprod, June 1, 2003; 68(6): 2215 - 2221. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Dixit, R. Sridaran, M. A. Edmonsond, D. Taub, and W. E. Thompson Gonadotropin-Releasing Hormone Attenuates Pregnancy-Associated Thymic Involution and Modulates the Expression of Antiproliferative Gene Product Prohibitin Endocrinology, April 1, 2003; 144(4): 1496 - 1505. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yesilova, M. Ozata, I. H. Kocar, M. Turan, A. Pekel, A. Sengul, and I. C. Ozdemír The Effects of Gonadotropin Treatment on the Immunological Features of Male Patients with Idiopathic Hypogonadotropic Hypogonadism J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 66 - 70. [Abstract] [Full Text] |
||||
![]() |
J. D. Jacobson, M. A. Ansari, M. Kinealy, and V. Muthukrishnan Gender-Specific Exacerbation of Murine Lupus by Gonadotropin-Releasing Hormone: Potential Role of G{alpha}q/11 Endocrinology, August 1, 1999; 140(8): 3429 - 3437. [Abstract] [Full Text] |
||||
![]() |
H.-F. Chen, E.-B. Jeung, M. Stephenson, and P. C. K. Leung Human Peripheral Blood Mononuclear Cells Express Gonadotropin-Releasing Hormone (GnRH), GnRH Receptor, and Interleukin-2 Receptor {gamma}-Chain Messenger Ribonucleic Acids That Are Regulated by GnRH in Vitro J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 743 - 750. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |